As per the results of a large scale survey conducted across India in 2020, ** percent stated of the respondents claimed that they prefered to take either Bharat Biotech's Covaxin or Serum Institute of India's Covishield vaccine against COVID-19. However, ** percent of respondents did not prefer both the vaccines that were available in the country at that time.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
GOQii. (February 12, 2021). Preferred COVID-19 vaccine across India in 2020, by type [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 26, 2026, from /statistics/1249889/india-preferred-covid-19-vaccine-by-type/
GOQii. "Preferred COVID-19 vaccine across India in 2020, by type." Chart. February 12, 2021. ÌÇÐÄÆÆ½â°æ. Accessed July 26, 2026. /statistics/1249889/india-preferred-covid-19-vaccine-by-type/
GOQii. (2021). Preferred COVID-19 vaccine across India in 2020, by type. ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 26, 2026. /statistics/1249889/india-preferred-covid-19-vaccine-by-type/
GOQii. "Preferred Covid-19 Vaccine across India in 2020, by Type." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 12 Feb 2021, /statistics/1249889/india-preferred-covid-19-vaccine-by-type/
GOQii, Preferred COVID-19 vaccine across India in 2020, by type ÌÇÐÄÆÆ½â°æ, /statistics/1249889/india-preferred-covid-19-vaccine-by-type/ (last visited July 26, 2026)
Preferred COVID-19 vaccine across India in 2020, by type [Graph], GOQii, February 12, 2021. [Online]. Available: /statistics/1249889/india-preferred-covid-19-vaccine-by-type/